Patient Guide: A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05209295
Status: ACTIVE_NOT_RECRUITING
Condition: Hepatic Insufficiency, Neoplasms
Phase: PHASE1

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Iowa City, Iowa
  • • Detroit, Michigan
  • • Cleveland, Ohio
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies - Join Clinical Trial NCTNCT05209295

How to Join This Clinical Trial - NCTNCT05209295

Learn how to participate in this PHASE1 trial studying an investigational therapy for Hepatic Insufficiency, Neoplasms. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hepatic Insufficiency, Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hepatic Insufficiency, Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05209295 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: Contact for availability

Clinical Research Site

Detroit, Michigan 48202 - United States

Status: Contact for availability

Clinical Research Site

Cleveland, Ohio 44106 - United States

Status: Contact for availability

Clinical Research Site

Charlottesville, Virginia 22903 - United States

Status: Contact for availability

Clinical Research Site

Pilar, Buenos Aires 1629 - Argentina

Status: Contact for availability

Clinical Research Site

ABB, Ciudad Autónoma De Buenos Aires C1199ABB - Argentina

Status: Contact for availability

Clinical Research Site

Buenos Aires, Ciudad Autónoma De Buenos Aires C1118AAT - Argentina

Status: Contact for availability

Clinical Research Site

Buenos Aires, 1426 - Argentina

Status: Contact for availability

Clinical Research Site

Bogota, Cundinamarca 111151 - Colombia

Status: Contact for availability

Clinical Research Site

Bogotá, Distrito Capital De Bogotá 110131 - Colombia

Status: Contact for availability

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Hepatic Insufficiency, Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships